STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$6.88
-0.06 (-0.86%)
Open$7.02
Previous Close$6.94
Day High$7.23
Day Low$6.82
52W High$8.33
52W Low$0.71
Volume—
Avg Volume2.44M
Market Cap637.13M
P/E Ratio—
EPS$-0.64
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+614.2% upside
Current
$6.88
$6.88
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.33M | 1.16M | 31.76M |
| Net Income | -64,953,449 | -50,639,383 | 1.18M |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% |
| EBITDA | -63,638,452 | -52,370,520 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | +15.4% | +15.4% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |